United States · Platforms & data · Finviz

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Published by Finviz · United States 3 d ago

AUSTIN, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE)-- FocalTherics (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that it will release its…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

The Motley Fool

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Investing.com

Oppenheimer reiterates Amgen stock rating on cancer drug data

MarketBeat

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Seeking Alpha

Roche lung cancer drug extends survival by nearly six months in late-stage trial

MarketWatch

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

TheStreet